+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genome Editing Market by Technology (Base Editing, Crispr, Megatal), Application (Agricultural, Industrial Biotechnology, Research), End User, Therapeutic Area, Delivery Method - Global Forecast 2025-2030- Product Image
Genome Editing Market by Technology (Base Editing, Crispr, Megatal), Application (Agricultural, Industrial Biotechnology, Research), End User, Therapeutic Area, Delivery Method - Global Forecast 2025-2030- Product Image
Sale

Genome Editing Market by Technology (Base Editing, Crispr, Megatal), Application (Agricultural, Industrial Biotechnology, Research), End User, Therapeutic Area, Delivery Method - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336238
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Genome editing is driving transformative shifts across research, healthcare, agriculture, and industrial biotechnology. As new editing platforms and delivery methods mature, senior leaders must anticipate evolving application boundaries and align their strategies with a rapidly growing innovation landscape.

Market Snapshot: Genome Editing Market Size and Growth

The Genome Editing Market grew from USD 16.54 billion in 2024 to USD 25.78 billion in 2025. With an expected CAGR of 53.38%, the market is projected to reach USD 215.42 billion by 2030. Sustained growth is being driven by innovation in gene-editing technologies, new therapeutic and agricultural applications, supportive regulatory environments, and a broadening end-user base.

Scope & Segmentation

  • Technologies: Covers CRISPR (Cas9, Cas12, Cas13), base editing (adenine, cytosine), prime editing, TALEN, meganucleases, and ZFN platforms.
  • Applications: Includes therapeutics (gene and cell therapies), agricultural (crop and livestock improvement), industrial biotechnology (biofuels, biomanufacturing), and foundational research (basic science, drug discovery).
  • End Users: Encompasses academic institutes, contract research organizations, and pharmaceutical and biotechnology companies.
  • Therapeutic Areas: Spans cardiology, oncology, neuroscience, infectious diseases, and genetic disorders, reflecting broad therapeutic impact.
  • Delivery Methods: Encompasses nonviral methods (electroporation, lipid nanoparticles), physical techniques (gene gun, microinjection), and viral vectors.
  • Geographies: Regional insights extend across the Americas (including United States, Canada, Brazil), Europe, Middle East & Africa (such as Germany, UK, France, Saudi Arabia, South Africa), and Asia-Pacific (China, India, Japan, Australia, Singapore).
  • Company Coverage: Profiles key players including Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies, Lonza Group AG, Sartorius AG, Becton Dickinson and Company, CRISPR Therapeutics AG, Intellia Therapeutics, and Sangamo Therapeutics.

Key Takeaways for Senior Decision-Makers

  • Diverse genome editing platforms are now foundational tools in bioscience, with newer technologies such as prime and base editors offering enhanced precision and versatility.
  • Convergence with automation and AI accelerates experiment design, analysis, and translational development across all major application segments.
  • Flexible licensing and service-oriented business models are enabling nimble collaborations and broader market access for both emerging innovators and established firms.
  • Shifting regulatory frameworks and ethical guidance require proactive stakeholder engagement and transparent risk governance to support long-term innovation.
  • Regional differences in infrastructure, funding, and regulatory pathways influence technology adoption and strategic partnerships, supporting local and multinational growth trajectories.
  • Strategic partnerships between industry, academia, and contract organizations are shortening development timelines and expanding access to next-generation genome editing capabilities.

Tariff Impact: Navigating U.S. Trade Dynamics

Recent tariff measures introduced by the United States in 2025 have impacted genome editing material supply chains, prompting organizations to reassess procurement and supplier strategies. The result is greater diversification of sourcing, increased investment in domestic manufacturing, and renewed emphasis on resilient inventory management. Adaptation to these trade conditions has fostered collaborative consortia and amended international contracts, creating a more flexible ecosystem for ongoing research and manufacturing.

Methodology & Data Sources

This analysis integrates primary interviews with sector experts, scientists, and executives, combined with secondary research from scientific literature, patent records, regulatory filings, and industry reports. An advisory panel validated insights and refined key findings, ensuring depth and reliability.

Why This Report Matters

  • Provides actionable segmentation and regional analysis supporting targeted R&D, investment, and partnership strategies.
  • Identifies competitive differentiation and technology adoption trends to inform opportunity assessment and risk management.
  • Facilitates alignment with evolving policy, regulatory, and supply chain dynamics critical to sustaining innovation and commercial success.

Conclusion

The genome editing sector is evolving rapidly, with technological innovation, regulatory frameworks, and cross-disciplinary collaboration shaping its future potential. Strategic agility and effective partnerships will remain essential for senior leaders working to capture emerging opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in base and prime editing technologies for precise single-nucleotide modifications
5.2. Integration of AI-driven bioinformatics platforms in guiding CRISPR target selection
5.3. Development of nonviral delivery systems for in vivo genome editing therapies
5.4. Regulatory harmonization efforts for global approval of gene editing therapeutics
5.5. Ethical and societal challenges surrounding germline genome editing applications
5.6. Expansion of CRISPR diagnostics in rapid infectious disease detection and surveillance
5.7. Commercialization of gene edited cell therapies for hematological disorders and cancers
5.8. Growth of insect gene drive projects for vector-borne disease control and ecological risk assessment
5.9. Emergence of anti-CRISPR proteins as safety switches in genome editing protocols
5.10. Advances in multiplex genome editing for engineering complex genetic circuits in cells
5.11. Strategic partnerships between biopharma and tech companies to accelerate genome editing research
5.12. Patent landscape shifts after recent Supreme Court rulings on CRISPR intellectual property
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Genome Editing Market, by Technology
8.1. Introduction
8.2. Base Editing
8.2.1. Adenine Base Editor
8.2.2. Cytosine Base Editor
8.3. Crispr
8.3.1. Cas12
8.3.2. Cas13
8.3.3. Cas9
8.4. Megatal
8.5. Prime Editing
8.6. Talen
8.7. Zfn
9. Genome Editing Market, by Application
9.1. Introduction
9.2. Agricultural
9.2.1. Crop Improvement
9.2.2. Livestock Improvement
9.3. Industrial Biotechnology
9.3.1. Biofuels
9.3.2. Biomanufacturing
9.4. Research
9.4.1. Basic Research
9.4.2. Drug Discovery
9.5. Therapeutics
9.5.1. Cell Therapy
9.5.2. Gene Therapy
10. Genome Editing Market, by End User
10.1. Introduction
10.2. Academic Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical Biotech
11. Genome Editing Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiology
11.3. Genetic Disorders
11.4. Infectious Diseases
11.5. Neurology
11.6. Oncology
12. Genome Editing Market, by Delivery Method
12.1. Introduction
12.2. Nonviral
12.2.1. Electroporation
12.2.2. Lipid Nanoparticles
12.3. Physical Methods
12.3.1. Gene Gun
12.3.2. Microinjection
12.4. Viral Vector
13. Americas Genome Editing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Genome Editing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Genome Editing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Danaher Corporation
16.3.3. Merck KGaA
16.3.4. Agilent Technologies, Inc.
16.3.5. Lonza Group AG
16.3.6. Sartorius AG
16.3.7. Becton Dickinson and Company
16.3.8. CRISPR Therapeutics AG
16.3.9. Intellia Therapeutics, Inc.
16.3.10. Sangamo Therapeutics, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GENOME EDITING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. GENOME EDITING MARKET: RESEARCHAI
FIGURE 26. GENOME EDITING MARKET: RESEARCHSTATISTICS
FIGURE 27. GENOME EDITING MARKET: RESEARCHCONTACTS
FIGURE 28. GENOME EDITING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GENOME EDITING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENOME EDITING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GENOME EDITING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GENOME EDITING MARKET SIZE, BY BASE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GENOME EDITING MARKET SIZE, BY BASE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GENOME EDITING MARKET SIZE, BY ADENINE BASE EDITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GENOME EDITING MARKET SIZE, BY ADENINE BASE EDITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GENOME EDITING MARKET SIZE, BY CYTOSINE BASE EDITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GENOME EDITING MARKET SIZE, BY CYTOSINE BASE EDITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GENOME EDITING MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GENOME EDITING MARKET SIZE, BY CRISPR, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GENOME EDITING MARKET SIZE, BY CRISPR, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GENOME EDITING MARKET SIZE, BY CAS12, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GENOME EDITING MARKET SIZE, BY CAS12, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GENOME EDITING MARKET SIZE, BY CAS13, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GENOME EDITING MARKET SIZE, BY CAS13, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GENOME EDITING MARKET SIZE, BY CAS9, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GENOME EDITING MARKET SIZE, BY CAS9, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GENOME EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GENOME EDITING MARKET SIZE, BY MEGATAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GENOME EDITING MARKET SIZE, BY MEGATAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GENOME EDITING MARKET SIZE, BY PRIME EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GENOME EDITING MARKET SIZE, BY PRIME EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GENOME EDITING MARKET SIZE, BY TALEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GENOME EDITING MARKET SIZE, BY TALEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GENOME EDITING MARKET SIZE, BY ZFN, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GENOME EDITING MARKET SIZE, BY ZFN, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GENOME EDITING MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GENOME EDITING MARKET SIZE, BY AGRICULTURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GENOME EDITING MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GENOME EDITING MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GENOME EDITING MARKET SIZE, BY LIVESTOCK IMPROVEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GENOME EDITING MARKET SIZE, BY LIVESTOCK IMPROVEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GENOME EDITING MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GENOME EDITING MARKET SIZE, BY BIOFUELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GENOME EDITING MARKET SIZE, BY BIOMANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GENOME EDITING MARKET SIZE, BY BIOMANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GENOME EDITING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GENOME EDITING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GENOME EDITING MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GENOME EDITING MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GENOME EDITING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GENOME EDITING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GENOME EDITING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GENOME EDITING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GENOME EDITING MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GENOME EDITING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GENOME EDITING MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GENOME EDITING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GENOME EDITING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GENOME EDITING MARKET SIZE, BY PHARMACEUTICAL BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GENOME EDITING MARKET SIZE, BY PHARMACEUTICAL BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GENOME EDITING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GENOME EDITING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GENOME EDITING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GENOME EDITING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GENOME EDITING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GENOME EDITING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GENOME EDITING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GENOME EDITING MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GENOME EDITING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GENOME EDITING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL GENOME EDITING MARKET SIZE, BY NONVIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL GENOME EDITING MARKET SIZE, BY NONVIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL GENOME EDITING MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL GENOME EDITING MARKET SIZE, BY ELECTROPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL GENOME EDITING MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL GENOME EDITING MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL GENOME EDITING MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL GENOME EDITING MARKET SIZE, BY GENE GUN, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL GENOME EDITING MARKET SIZE, BY GENE GUN, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL GENOME EDITING MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL GENOME EDITING MARKET SIZE, BY MICROINJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL GENOME EDITING MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL GENOME EDITING MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS GENOME EDITING MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS GENOME EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS GENOME EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS GENOME EDITING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS GENOME EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS GENOME EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS GENOME EDITING MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS GENOME EDITING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES GENOME EDITING MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES GENOME EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES GENOME EDITING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES GENOME EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES GENOME EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES GENOME EDITING MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES GENOME EDITING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 167. CANADA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. CANADA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. CANADA GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 170. CANADA GENOME EDITING MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 171. CANADA GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 172. CANADA GENOME EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 173. CANADA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. CANADA GENOME EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. CANADA GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 176. CANADA GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 177. CANADA GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. CANADA GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. CANADA GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 180. CANADA GENOME EDITING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 181. CANADA GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 182. CANADA GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 183. CANADA GENOME EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. CANADA GENOME EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. CANADA GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 186. CANADA GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 187. CANADA GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 188. CANADA GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 189. CANADA GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 190. CANADA GENOME EDITING MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 191. CANADA GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2024 (USD MILLION)
TABLE 192. CANADA GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. MEXICO GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. MEXICO GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 196. MEXICO GENOME EDITING MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 197. MEXICO GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 198. MEXICO GENOME EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 199. MEXICO GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. MEXICO GENOME EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. MEXICO GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 202. MEXICO GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 203. MEXICO GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. MEXICO GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. MEXICO GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 206. MEXICO GENOME EDITING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 207. MEXICO GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO GENOME EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. MEXICO GENOME EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. MEXICO GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 212. MEXICO GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 213. MEXICO GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 214. MEXICO GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 215. MEXICO GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 216. MEXICO GENOME EDITING MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 217. MEXICO GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL GENOME EDITING MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL GENOME EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL GENOME EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL GENOME EDITING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL GENOME EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL GENOME EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL GENOME EDITING MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA GENOME EDITING MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA GENOME EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA GENOME EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA GENOME EDITING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA GENOME EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA GENOME EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA GENOME EDITING MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 322. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2024 (USD MILLION)
TABLE 324. UNITED KINGDOM GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2025-2030 (USD MILLION)
TABLE 325. GERMANY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 326. GERMANY GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 327. GERMANY GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 328. GERMANY GENOME EDITING MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 329. GERMANY GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 330. GERMANY GENOME EDITING MARKET SIZE, BY CRISPR, 2025-2030 (USD MILLION)
TABLE 331. GERMANY GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 332. GERMANY GENOME EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 333. GERMANY GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2024 (USD MILLION)
TABLE 334. GERMANY GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2025-2030 (USD MILLION)
TABLE 335. GERMANY GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 336. GERMANY GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 337. GERMANY GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 338. GERMANY GENOME EDITING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 339. GERMANY GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 340. GERMANY GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 341. GERMANY GENOME EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. GERMANY GENOME EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. GERMANY GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 344. GERMANY GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 345. GERMANY GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 346. GERMANY GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 347. GERMANY GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2024 (USD MILLION)
TABLE 348. GERMANY GENOME EDITING MARKET SIZE, BY NONVIRAL, 2025-2030 (USD MILLION)
TABLE 349. GERMANY GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2024 (USD MILLION)
TABLE 350. GERMANY GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2025-2030 (USD MILLION)
TABLE 351. FRANCE GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 352. FRANCE GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 353. FRANCE GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2024 (USD MILLION)
TABLE 354. FRANCE GENOME EDITING MARKET SIZE, BY BASE EDITING, 2025-2030 (USD MILLION)
TABLE 355. FRANCE GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2024 (USD MILLION)
TABLE 356. FRA

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Lonza Group AG
  • Sartorius AG
  • Becton Dickinson and Company
  • CRISPR Therapeutics AG
  • Intellia Therapeutics, Inc.
  • Sangamo Therapeutics, Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 25.78 Billion
Forecasted Market Value ( USD ) by 2030 $ 215.42 Billion
Compound Annual Growth Rate53.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Mutation Detection Kits In Genome Editing Market by Technology (Cripsr, Meaganuclease, Talen), Detection Method (High Resolution Melt Analysis, Ngs, Pcr), Application, End User, Distribution Channel, Workflow Stage - Global Forecast 2025-2030 - Product Image

Mutation Detection Kits In Genome Editing Market by Technology (Cripsr, Meaganuclease, Talen), Detection Method (High Resolution Melt Analysis, Ngs, Pcr), Application, End User, Distribution Channel, Workflow Stage - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9), Delivery Method (Ex Vivo), Application (Genetic Engineering, Clinical Applications), Mode (Contract, in-house), End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9), Delivery Method (Ex Vivo), Application (Genetic Engineering, Clinical Applications), Mode (Contract, in-house), End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Genome Engineering Market by Technology (CRISPR Systems, Meganucleases, Transcription Activator Like Effector Nucleases), Product (Instruments, Reagents & Consumables, Software & Services), Application, End User - Global Forecast 2025-2030 - Product Image

Genome Engineering Market by Technology (CRISPR Systems, Meganucleases, Transcription Activator Like Effector Nucleases), Product (Instruments, Reagents & Consumables, Software & Services), Application, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Genome Editing / Genome Engineering - Global Strategic Business Report - Product Image

Genome Editing / Genome Engineering - Global Strategic Business Report

  • Report
  • 187 Pages
  • Global
From
Genome Editing Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F - Product Image

Genome Editing Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.